Digital Dose Inhaler Market Set to Garner High Revenues Owing to Increasing Prevalence of Respiratory Diseases

 
Digital Dose Inhaler Market

The digital dose inhaler market is anticipated to witness substantial growth due to rising cases of respiratory diseases across the globe. Digital dose inhalers help in delivery of medication directly to the airways through deep inhalation. These devices address issues with traditional pressurized metered dose inhalers and dry powder inhalers such as inadequate coordination between actuation and inhalation. Digital dose inhalers offer dose counter integration, connectivity capabilities, and customizable dose reminders which help patients in effective therapy management of asthma and chronic obstructive pulmonary disease (COPD). The Global Digital Dose Inhaler Market is estimated to be valued at US$ 18.33 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Digital Dose Inhaler Market Demand are 3M, AstraZeneca, GLENMARK PHARMACEUTICALS LTD., Novartis AG, Sensirion AG, Propeller Health, OPKO Health, Inc., Teva Pharmaceutical Industries Ltd., BEXIMCO Pharmaceuticals, GSK plc., Mundipharma International, Honeywell International Inc., Veranex, Cognita Labs. 3M, AstraZeneca and Novartis AG currently dominate the market.

The digital dose inhalers offer various opportunities such as integration of dose counters and connectivity capabilities in traditional inhalers. This feature allows patients to digitally track medication use and share data with physicians. The connectivity further enables physicians to remotely monitor patients and optimize treatment plans.

The major players are focusing on global expansion to consolidate their market presence. For instance, in 2021, Propeller Health expanded into Germany by partnering with global pharmaceutical company Teva. Similarly, Cognita Labs has collaborations in Europe and Asia to commercialize its digital inhaler products.

Market drivers: Rising patient non-adherence to inhaler medications due to complex treatment regimens is a key factor driving adoption of smart inhalers. Integrated features in digital dose inhalers help users adhere to prescribed treatments and therapy plans.

Market restraints: High product and development costs associated with digital dose inhalers limit their widespread adoption. Further, availability of generic versions of conventional inhalers at lower prices poses pricing challenges for digital variants. Lack of internet connectivity or digital skills in certain regions also restraint market potential currently.

Segment Analysis

The digital dose inhaler market can be segmented based on product type, application, end user and region. By product type, the dry powder inhalers segment is expected to dominate during the forecast period as they are user friendly and easier to carry for patients as compared to other inhaler types. By application, the asthma segment accounts for the largest market share currently due to the high prevalence of asthma across the globe. Hospitals dominated the end user segment in 2024 as digital dose inhalers are prescribed majorly during hospital visits or when asthma exacerbations occur.

Global Analysis

Regionally, North America holds the highest share of the digital dose inhaler market and is expected to remain dominant during the forecast period. This is majorly due to well-established healthcare infrastructure and rising healthcare expenditure in the region. However, Asia Pacific is expected witness the highest growth rate owing to fast adoption of advanced technologies, growing pollution levels and increasing healthcare expenditure in emerging countries such as China and India. Key players are focusing on expanding their digital dose inhaler portfolio and entering partnerships to strengthen their market presence across different regions globally.

Get more insights on Digital Dose Inhaler Market

Comments

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Automation of Agricultural Operations to Drive the Agricultural Drones Market Growth